Preview

Modern Science and Innovations

Advanced search

Correction of immunodeficiency in mice with a biologically active substance of tissue origin

https://doi.org/10.37493/2307-910X.2021.2.10

Abstract

Immunodeficiency conditions in which immune deficiency occurs or is formed as a weak immune response to the introduction of an antigen. Primary immunodeficiency (PID) is a disease of the immune system that is inherited. More than 400 such diseases are known. Timely information about the presence of PID allows timely prevention of relapses and treatment. Therefore, knowing the etiology of PID, since it is an acquired clinical and immunological syndrome, it can be eliminated by eliminating the causes that cause it, the development of PID is influenced by age, unbalanced nutrition, metabolic disorders (diabetes mellitus), external factors that can cause stress, exposure to radioactive, ultraviolet radiation, etc..d. In this regard, there is a need to search for a rational prevention of PID, by eliminating the causes of the occurrence and restoring the immune status of the organism with the help of biologically active substances of immunomodulatory action with the absence of side effects.

About the Authors

N. A. Kolberg
Ural State Economic University
Russian Federation


S. L. Tikhonov
Ural State Economic University
Russian Federation


N. V. Tikhonova
Ural State Economic University
Russian Federation


S. A. Leontyeva
Ural State Economic University
Russian Federation


References

1. Bousfiha A.A., Jeddane L., Ailal F. et al. Primary immunodeficiency diseases worldwide: more common than generally thought // J. Clin. Immunol. 2013. Vol. 33, N 1. Р. 1-7.

2. Boyarchuk O., Lewandowicz-Uszynska A., Kinash M. et al. Physicians' awareness concerning primary immunodeficiencies in the Ternopil Region of Ukraine // PediatriaPolska (Polish J. Paediatr). 2018. Vol. 93, N 3. Р. 221-228.

3. Кинаш М.И., Боярчук О.Р., Гариян Т.В., Добровольская Л.И. Вопросы совершенствования знаний о первичных иммунодефицитах // Вопросы практической педиатрии. 2019. T. 14, № 6. С. 55-62. DOI: 10.20953/1817-7646-2019-6-55.

4. Boyarchuk O., Kinash M., Hariyan T., Bakalyuk T. Evaluation of knowledge about primary immunodeficiencies among postgraduate medical students // Arch. Balkan Med. Union. 2019. Vol. 54, N 1. P. 11-19.

5. Чернишова Л.1., Волоха А.П., Костюченко Л.В. та ш. Дшяшмунолопя. Кшв : Медицина, 2013. 720 с.

6. Самсыгина Г.А., Выжлова Е.Н. Еще раз о проблемах понятия "часто болеющие дети" // Педиатрия.2016. Т. 95, № 4. С. 209-215.

7. Boyarchuk O., Volokha A., Hariyan T. et al. The impact of combining educational program with the improving of infrastructure to diagnose on early detection of primary immunodeficiencies in children // Immunol. Res. 2019. Vol. 67, N 4-5. P. 390-397.

8. Slatter M.A., Gennery A.R. Clinical immunology review series: an approach to the patient with recurrent infections in childhood // Clin. Exp. Immunol. 2008. Vol. 152, N 3. P. 389-396. DOI: 10.1111/j.1365- 2249.2008.03641.x.

9. Boyarchuk O., Dmytrash L. Clinical manifestations in the patients with primary immunodeficiencies: data from One Regional Center // Turk. J. Immunol. 2019. Vol. 7, N 3. P. 113-119.


Review

For citations:


Kolberg N.A., Tikhonov S.L., Tikhonova N.V., Leontyeva S.A. Correction of immunodeficiency in mice with a biologically active substance of tissue origin. Modern Science and Innovations. 2021;(2):107-118. (In Russ.) https://doi.org/10.37493/2307-910X.2021.2.10

Views: 61


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2307-910X (Print)